Late treatment study
et al., medRxiv, doi:10.1101/2020.05.12.20099028 (Preprint)
Outcomes of Hydroxych loroquine Treatment Among Hospitalized COVID-19 Patients in the United States- Real-World Evidence From a Federated Electronic Medical Record Network
EHR analysis of 3,372 hospitalized COVID-19 patients not showing a significant difference for mortality or the risk of mechanical ventilation. Subject to the limitations of EHR analysis. Misclassification is possible. Confounding by indication.
death, ↓5.0%, p=0.72
ventilation, ↓19.0%, p=0.26
Please send us corrections, updates, or comments.